Skip to main content
Clinical Trials/NCT02444273
NCT02444273
Completed
N/A

The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish Hospital

Washington University School of Medicine0 sites101 target enrollmentOctober 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
End Stage Liver Disease
Sponsor
Washington University School of Medicine
Enrollment
101
Primary Endpoint
Feasibility of a prehabilitation program.
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The primary outcome of this study is to demonstrate the feasibility of a prehabilitation program at Barnes Jewish Hospital for liver transplant candidates. Those patients who consent to participate in the study and are placed on the transplant list will be randomized into either the control or intervention group. The intervention group receives a personalized home exercise program along with weekly phone calls to provide coaching, mentoring and motivation. Data collected at baseline, post-transplant and, post-transplant follow up will be compared among the two study groups. The secondary outcomes include: normative data of functional measures for patients with end stage liver disease and to determine the effect size for future research on prehabilitation in the patient population.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
December 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Being evaluated for liver transplantation by Barnes Jewish Hospital medical team

Exclusion Criteria

  • Non-english speaking
  • Medical contraindications to exercise as determined by the medical team

Outcomes

Primary Outcomes

Feasibility of a prehabilitation program.

Time Frame: 2 Years

Feasibility will be measured by participation and outcome assessment measures.

Secondary Outcomes

  • Normative data on 10 meter walk for patients with end stage liver disease.(Baseline)
  • Normative data on Timed Up and Go for patients with end stage liver disease.(Baseline)
  • Normative data on Modified Dynamic Gait Index for patients with end stage liver disease.(Baseline)
  • Normative data on Five Time Sit to Stand for patients with end stage liver disease.(Baseline)
  • Normative data on 6 Minute Walk Test for patients with end stage liver disease.(Baseline)

Similar Trials